Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Bio-Techne Corp (TECH) Ordinary USD0.01

Sell:$274.78 Buy:$278.28 Change: $4.45 (1.62%)
NASDAQ:0.43%
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$274.78
Buy:$278.28
Change: $4.45 (1.62%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$274.78
Buy:$278.28
Change: $4.45 (1.62%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market.

Contact details

Address:
614 McKinley Pl NE
MINNEAPOLIS
55413-2610
United States
Telephone:
+1 (612) 3798854
Website:
https://www.bio-techne.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TECH
ISIN:
US09073M1045
Market cap:
$10.20 billion
Shares in issue:
38.22 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Robert Baumgartner
    Independent Chairman of the Board
  • Charles Kummeth
    President, Chief Executive Officer, Director
  • James Hippel
    Chief Financial Officer, Senior Vice President - Finance
  • David Eansor
    President - Protein Sciences
  • Kim Kelderman
    President - Diagnostics and Genomics
  • Brenda Furlow
    Senior Vice President, General Counsel, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.